Upstream Bio Leads Three Life Sciences IPOs With Upsized Listing [Yahoo! Finance]
Upstream Bio, Inc. (UPB)
Company Research
Source: Yahoo! Finance
Most Read from Bloomberg Drug developer Upstream Bio Inc. expanded the size of its share sale to raise $255 million. The company, based in Waltham, Massachusetts, sold 15 million shares for $17 each, according to a statement, after marketing 12.5 million for $15 to $17. Also Thursday, Camp4 Therapeutics Corp. said in a statement that it sold 6.82 million shares for $11 apiece to raise $75 million. By increasing the size of the offering, Camp4 hit the mid-range of its earlier target even though it priced the shares below the marketed range. The last of the trio, device maker CeriBell Inc., is seeking to raise almost $170 million in its offering, also set to price Thursday. The deals follow a spate of IPOs and follow-on offerings last month from companies including Bicara Therapeutics Inc., MBX Biosciences Inc. and Xencor Inc., some of which proved popular enough to be upsized. Upstream Bio, which is backed by the likes of OrbiMed and TCG Crossover Management, is developing d
Show less
Read more
Impact Snapshot
Event Time:
UPB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UPB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UPB alerts
High impacting Upstream Bio, Inc. news events
Weekly update
A roundup of the hottest topics
UPB
News
- Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswire
- Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business HighlightsGlobeNewswire
- Upstream Bio, Inc. (NASDAQ: UPB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $75.00 price target on the stock.MarketBeat
- Upstream Bio, Inc. (NASDAQ: UPB) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $38.00 price target on the stock.MarketBeat
- Upstream Bio, Inc. (NASDAQ: UPB) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.MarketBeat
UPB
Sec Filings
- 11/8/24 - Form SEC
- 11/8/24 - Form SEC
- 11/7/24 - Form SC
- UPB's page on the SEC website